Sbc Medical Group Holdings Inc (SBC) financials
Sbc Medical Group revenue and earnings by year
Sbc Medical Group's revenue was $174 million in the fiscal year to December 31, 2025, down 15.5% from the year before. Net income was $51.0 million, 29.4% of revenue. Since the fiscal year to December 31, 2022, revenue has shrunk 0.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 4 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 174 | 205 | 194 | 174 |
| Revenue growth | -15.5% | 6.1% | 11.1% | — |
| Gross profit | 127 | 156 | 137 | 115 |
| Gross margin | 73.3% | 76.0% | 70.9% | 65.9% |
| Operating income | 67 | 70 | 71 | 20 |
| Operating margin | 38.9% | 34.2% | 36.5% | 11.6% |
| Net income | 51 | 47 | 39 | 6 |
| Net margin | 29.4% | 22.7% | 20.3% | 3.6% |
| Diluted EPS | $0.50 | $0.48 | $0.42 | — |
| Free cash flow | 20 | 17 | 49 | -23 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SBC in Markets.
See also: SBC valuation and P/E history · SBC returns
No forecast, no recommendation. This page describes Sbc Medical Group Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.